secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001493152-24-027867
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics announces 1-for-10 reverse stock split effective July 15, 2024
--------------------------------------------------------------------------------

- Reverse stock split at a 1-for-10 ratio, effective 12:01 a.m. ET on July 15, 2024.
- Stockholder approval obtained at special meeting on June 6, 2024; Board set ratio at 1:10.
- No fractional shares will be issued; fractional shares rounded up to the next whole number.
- Authorized shares of common stock remain unchanged at 330,000,000 shares.
- Trading symbol remains CLDI; new CUSIP number for common stock is 320703309.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224027867/0001493152-24-027867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224027867/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-027867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer